Cause of death, by non-communicable diseases, male in Kazakhstan
Kazakhstan: Cause of death, by non-communicable diseases, male was 55.1% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, male in Kazakhstan, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths.
Analysis
The most recent figure for cause of death, by non-communicable diseases, male in Kazakhstan is 55.1%, measured in 2021. That is the lowest value across all 6 years on record.
Compared with earlier readings it is down 18.0% on the previous year and down 28.3% over ten years.
Over the whole period, cause of death, by non-communicable diseases, male in Kazakhstan peaked at 82.1% in 2019 and was at its lowest, 55.1%, in 2021.
Kazakhstan ranks 109th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, male in Kazakhstan, year by year
| Year | % of total male deaths | Change |
|---|---|---|
| 2000 | 72.9% | — |
| 2010 | 76.9% | +5.5% |
| 2015 | 80.2% | +4.3% |
| 2019 | 82.1% | +2.4% |
| 2020 | 67.2% | -18.2% |
| 2021 | 55.1% | -18.0% |
Kazakhstan compared with similar countries
- Kazakhstan's 55.1% is below the median for upper middle income countries, which is 59.4%, 93% of the median. (55 countries reporting)
- Kazakhstan's 55.1% is below the median for Europe & Central Asia, which is 75.7%, 73% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 72.9% | 72.9% | 72.9% | 1 |
| 2010s | 79.7% | 76.9% | 82.1% | 3 |
| 2020s | 61.2% | 55.1% | 67.2% | 2 |
Countries ranked near Kazakhstan
More health data for Kazakhstan
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3158 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 825.8 deaths per 1,000 people (2090)
- Number of infants who die before age 1 660 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.58 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0485 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.16 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, male in Kazakhstan?
- Cause of death, by non-communicable diseases, male in Kazakhstan was 55.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, male recorded in Kazakhstan?
- The highest recorded value was 82.1% in 2019.
- What is the lowest cause of death, by non-communicable diseases, male recorded in Kazakhstan?
- The lowest recorded value was 55.1% in 2021.
- How does Kazakhstan rank for cause of death, by non-communicable diseases, male?
- Kazakhstan ranks 109th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, male rising or falling in Kazakhstan?
- Over the last ten years it is down 28.3%. The long-run trend across the full record is falling.
- Where does this Kazakhstan data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.